Cipla Ltd.

United States Food and Drug Administration (USFDA) has classified inspection conducted at Cipla’s wholly-owned subsidiary -- Medispray Laboratories’ manufacturing facility located in Goa as Voluntary Action Indicated (VAI). USFDA had conducted the inspection at said facility from January 14 to January 20, 2025.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.